Rhodiola sp. can reduce TNF-α, transforming growth factor beta 1, and IL-6 levels in the BALF in a concentration-dependent manner and inhibit inflammatory injury caused by cerebral ischemia in rats, slowing the progression of brain edema [41]. Here, TNF is linked to brain ischemia.